ContraFect's IPO

ContraFect raised a round of funding on July 29, 2014. Investors include Public.

ContraFect is a biotechnology company committed to developing technologies, treatments, and products that will target and kill the most virulent and resistant microorganisms-including gram-positive ba…

Articles about ContraFect's IPO: